Clinical Trial Update: TriPRIL CAR T Cells in Multiple Myeloma [Phase 1]

View source ↗

Summary

This document summarizes an ongoing Phase 1 clinical trial evaluating TriPRIL CAR T Cells in patients with multiple myeloma, including relapsed and refractory c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• TriPRIL CAR T Cells

Snippet

Sponsor: Marcela V. Maus, M.D.,Ph.D. | Conditions: Multiple Myeloma, Multiple Myeloma in Relapse | Phase 1 | Status: RECRUITING